What stock should value investors buy now?
Investors who are looking to buy stocks in the Medical – Products industry might consider LeMaitre Vascular or EssilorLuxotticaUnsponsored ADR. What stock is better for value investors right now than the other? We will need to look closer.
Combining a strong Zacks Rank and a highly rated grade in the Value section of our Style Scores program is the best way to identify great value stocks. Our Style Scores are used to identify stocks with particular traits.
LeMaitre Vascular, EssilorLuxottica and Unsponsored ADR of EssilorLuxottica are currently sporting Zacks ranks of #2 (Buy), and #4 (Sell). Investors should be happy with the improvement in ESLOY’s analyst outlook. This means that ESLOY has had more impressive earnings estimate revision activity. However, this is only one part of the puzzle for value-investors.
Value investors look at a range of traditional metrics and figures to determine if a company is undervalued at current share prices.
The Style Score Value score factors in a variety key fundamental metrics including the popular P/E, P/S, and earnings yield. There are also a few other key stats that value investors often use.
ESLOY currently has a forward PE ratio of 27.38 while LMAT has a forward PE ratio of 37.78. We also noticed that ESLOY’s PEG ratio is 1.30. This popular metric is very similar to the well-known P/E ratio. However, the PEG ratio also considers the company’s expected earnings growth rate. LMAT currently has a 3.78 PEG ratio.
A notable valuation metric for ESLOY’s is its P/B Ratio of 1.90. The P/B ratio is a measure of ESLOY’s stock’s market price versus its book value. This is the sum of total assets and total liabilities. LMAT’s P/B is 3.76.
These are just a handful of the metrics that contribute to ESLOY’s value grade of B, and LMAT’s value grade of C.
ESLOY has experienced stronger estimate revision activity, and LMAT sports more attractive valuation metrics. It seems that value investors will conclude that ESLOY offers a superior choice right now.
Want the latest Zacks Investment Research recommendations? You can now download 7 Best Stocks to Watch in the Next 30 days. Click to get this free report
EssilorLuxottica Unsponsored ADR (ESLOY) : Free Stock Analysis Report
LeMaitre Vascular, Inc. (LMAT) : Free Stock Analysis Report